RKTO

Hoth Therapeutics, Inc.

NASDAQ · Healthcare · Medical - Pharmaceuticals

Hoth Therapeutics, Inc. specializes in developing next-generation therapeutic approaches for a range of dermatological ailments. Its active development pipeline includes investigational treatments targeting conditions such as atopic dermatitis (more commonly known as eczema), persistent wounds, psoriasis, asthma, and acne. A key offering from the company is the BioLexa Platform, a proprietary drug compound system specifically engineered to address eczema. Founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017, the firm's main operations are situated in Hoboken, New Jersey.